Featured Article

The Implementation and First‐Round Results of a Community‐Based Colorectal Cancer Screening Program in Shanghai, China
Yangming Gong, Peng Peng, Pingping Bao, Weijian Zhong, Yan Shi, Kai Gu, Ying Zheng, Chunxiao Wu, Sanjun Cai, Ye Xu, Jun Sheng and Fan Wu
The Oncologist 2018; first published on March 14, 2018; doi: 10.1634/theoncologist.2017-0451


Recent Translated Articles from The Oncologist


Volume 23: Number 6, June 2018


Clinical Trial Results

Parsatuzumab(EGFL7抗体)或安慰剂联合卡铂、紫杉醇和贝伐单抗一线疗法治疗非鳞状非小细胞肺癌的随机II期试验
Randomized Phase II Trial of Parsatuzumab (Anti‐EGFL7) or Placebo in Combination with Carboplatin, Paclitaxel, and Bevacizumab for First‐Line Nonsquamous Non‐Small Cell Lung Cancer
Joachim von Pawel, David R. Spigel, Thomas Ervin, György Losonczy, Fabrice Barlesi, Erzsébet Juhász, Maria Anderson, Bruce McCall, Eric Wakshull, Priti Hegde, Weilan Ye, Daniel Chen, Ilsung Chang, Ina Rhee, Martin Reck
The Oncologist 2018; 23:654-e58; first published on February 7, 2018; doi:10.1634/theoncologist.2017-0690

Selinexor(核输出复合物的口服选择性抑制剂)治疗阿比特龙和/或恩杂鲁胺难治性转移性去势抵抗性前列腺癌的II期试验
A Phase II Trial of Selinexor, an Oral Selective Inhibitor of Nuclear Export Compound, in Abiraterone‐ and/or Enzalutamide‐Refractory Metastatic Castration‐Resistant Prostate Cancer
Xiao X. Wei, Adam P. Siegel, Rahul Aggarwal, Amy M. Lin, Terence W. Friedlander, Lawrence Fong, Won Kim, Mirela Louttit, Emily Chang, Li Zhang, Charles J. Ryan
The Oncologist 2018; 23:656-e64; first published on February 27, 2018; doi:10.1634/theoncologist.2017-0624

OPB-111077(小分子STAT3和氧化磷酸化抑制剂)治疗晚期癌症患者的首项人体1期研究
A First‐in‐Human Phase I Study of OPB‐111077, a Small‐Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers
Anthony Tolcher, Keith Flaherty, Geoffrey I. Shapiro, Jordan Berlin, Thomas Witzig, Thomas Habermann, Andrea Bullock, Edwin Rock, Agnes Elekes, Chester Lin, Dusan Kostic, Naoto Ohi, Drew Rasco, Kyriakos P. Papadopoulos, Amita Patnaik, Lon Smith, Gregory M. Cote
The Oncologist 2018; 23:658-e72; first published on March 6, 2018; doi:10.1634/theoncologist.2017-0325


Breast Cancer

关于乳腺癌中mTOR抑制剂相关非感染性肺炎的新角度
Emerging Perspectives on mTOR Inhibitor‐Associated Pneumonitis in Breast Cancer
Ricardo H. Alvarez, Rabih I. Bechara, Michael J. Naughton, Javier A. Adachi, James M. Reuben
The Oncologist 2018; 23:660-669; first published on February 27, 2018; doi:10.1634/theoncologist.2017-0343

新辅助化疗后残留乳腺癌中Ki67变化可识别更差预后
Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant Chemotherapy
Paula Cabrera‐Galeana, Wendy Muñoz‐Montaño, Fernando Lara‐Medina, Alberto Alvarado‐Miranda, Victor Pérez‐Sánchez, Cynthia Villarreal‐Garza, R. Marisol Quintero, Fany Porras‐Reyes, Enrique Bargallo‐Rocha, Ignacio Del Carmen, Alejandro Mohar, Oscar Arrieta
The Oncologist 2018; 23:670-678; first published on February 28, 2018; doi:10.1634/theoncologist.2017-0396


Gastrointestinal Cancer

针对转移性结直肠癌中孤立腹部淋巴结转移的一种根治性三联方法:单机构经验更新
A Curative‐Intent Trimodality Approach for Isolated Abdominal Nodal Metastases in Metastatic Colorectal Cancer: Update of a Single‐Institutional Experience
Benny Johnson, Zhaohui Jin, Michael G. Haddock, Christopher L. Hallemeier, James A. Martenson, Rory L. Smoot, David W. Larson, Eric J. Dozois, David M. Nagorney, Axel Grothey
The Oncologist 2018; 23:679-685; first published on February 14, 2018; doi:10.1634/theoncologist.2017-0456


Hematologic Malignancies

对弥漫性大B细胞淋巴瘤老年患者的年龄、合并症和白蛋白指数的验证和细化研究:一个有效的综合老年评估工具
Validation and Refinement of the Age, Comorbidities, and Albumin Index in Elderly Patients with Diffuse Large B‐Cell Lymphoma: An Effective Tool for Comprehensive Geriatric Assessment
Hui Liu, Chun‐Li Zhang, Ru Feng, Jiang‐Tao Li, Yuan Tian, Ting Wang
The Oncologist 2018; 23:722-729; first published on January 9, 2018; doi:10.1634/theoncologist.2017-0361


Symptom Management and Supportive Care

用于缓解由肝前型门静脉高压症引起的腹水和静脉曲张出血的门肠系膜静脉支架
Portomesenteric Venous Stenting for Palliation of Ascites and Variceal Bleeding Caused by Prehepatic Portal Hypertension
Rahul A. Sheth, Sharjeel H. Sabir, Philip Parmet, Roshon Amin, Joshua D. Kuban, Steven Y. Huang, Armeen Mahvash, David Fogelman, Milind Javle, Michael J. Wallace
The Oncologist 2018; 23:712-718; first published on December 28, 2017; doi:10.1634/theoncologist.2017-0337